Annual Accounts Receivable
$2.23 M
+$116.00 K+5.50%
December 1, 2023
Summary
- As of February 7, 2025, PTPI annual accounts receivable is $2.23 million, with the most recent change of +$116.00 thousand (+5.50%) on December 1, 2023.
- During the last 3 years, PTPI annual accounts receivable has fallen by -$2.93 million (-56.80%).
- PTPI annual accounts receivable is now -56.80% below its all-time high of $5.15 million, reached on December 31, 2020.
Performance
PTPI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.95 M
+$172.10 K+9.69%
September 1, 2024
Summary
- As of February 7, 2025, PTPI quarterly accounts receivable is $1.95 million, with the most recent change of +$172.10 thousand (+9.69%) on September 1, 2024.
- Over the past year, PTPI quarterly accounts receivable has dropped by -$1.03 million (-34.50%).
- PTPI quarterly accounts receivable is now -68.54% below its all-time high of $6.19 million, reached on March 31, 2021.
Performance
PTPI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
PTPI Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | -34.5% |
| 3 y3 years | -56.8% | -18.8% |
| 5 y5 years | -14.5% | -18.8% |
PTPI Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.3% | +5.5% | -66.1% | +9.7% |
| 5 y | 5-year | -56.8% | +5.5% | -68.5% | +9.7% |
| alltime | all time | -56.8% | +5.5% | -68.5% | +9.7% |
Petros Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.95 M(+9.7%) |
| Jun 2024 | - | $1.78 M(-9.2%) |
| Mar 2024 | - | $1.96 M(-12.1%) |
| Dec 2023 | $2.23 M(+5.5%) | $2.23 M(-25.2%) |
| Sep 2023 | - | $2.98 M(+15.5%) |
| Jun 2023 | - | $2.58 M(+7.4%) |
| Mar 2023 | - | $2.40 M(+13.7%) |
| Dec 2022 | $2.11 M | $2.11 M(-43.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $3.73 M(-35.1%) |
| Jun 2022 | - | $5.75 M(+53.7%) |
| Mar 2022 | - | $3.74 M(+52.3%) |
| Dec 2021 | $2.46 M(-52.4%) | $2.46 M(+25.8%) |
| Sep 2021 | - | $1.95 M(-3.4%) |
| Jun 2021 | - | $2.02 M(-67.4%) |
| Mar 2021 | - | $6.19 M(+20.2%) |
| Dec 2020 | $5.15 M(+97.8%) | $5.15 M |
| Dec 2019 | $2.61 M | - |
FAQ
- What is Petros Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals annual accounts receivable year-on-year change?
- What is Petros Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Petros Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of PTPI is $2.23 M
What is the all time high annual accounts receivable for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high annual accounts receivable is $5.15 M
What is Petros Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, PTPI annual accounts receivable has changed by +$116.00 K (+5.50%)
What is Petros Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of PTPI is $1.95 M
What is the all time high quarterly accounts receivable for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high quarterly accounts receivable is $6.19 M
What is Petros Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, PTPI quarterly accounts receivable has changed by -$1.03 M (-34.50%)